ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Deferasirox API Market Research Report 2024
Published Date: May 2024
|
Report Code: QYRE-Auto-26N5874
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Deferasirox API Market Insights Forecast to 2028
BUY CHAPTERS

Global Deferasirox API Market Research Report 2024

Code: QYRE-Auto-26N5874
Report
May 2024
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Piramal Enterprises Limited
Alkaloids Corporation
Zhejiang Hengkang Pharmaceutical
Om Pharmaceutical Industries
Teva API
Symed Labs Limited
Neuland Laboratories
Parabolic Drugs Limited
YUNG ZIP CHEMICAL INDUSTRIAL
Erregierre SpA
Glenmark Pharmaceuticals
Cipla Ltd
Sun Pharmaceutical Industries Ltd.
Jubilant Pharma
CTX Lifesciences
Waterstone Pharmaceuticals Inc.
Curequest Lifescience
Bal Pharma Ltd.

Deferasirox API Market

Deferasirox is a synthetic, orally bioavailable, achiral, tridentate triazole derived from salicylic acid with iron-chelating activity. Deferasirox chelates iron at a 2:1 (ligand:iron) ratio. Because of its oral availability and long plasma half-life, this agent may be superior to desferrioxamine (desferal, DFO), which is orally inactive and has a short plasma half-life.
The global Deferasirox API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Deferasirox API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Deferasirox API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Deferasirox API include Piramal Enterprises Limited, Alkaloids Corporation, Zhejiang Hengkang Pharmaceutical, Om Pharmaceutical Industries, Teva API, Symed Labs Limited, Neuland Laboratories, Parabolic Drugs Limited and YUNG ZIP CHEMICAL INDUSTRIAL, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Deferasirox API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Deferasirox API.

Report Scope

The Deferasirox API market size, estimations, and forecasts are provided in terms of output/shipments (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Deferasirox API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Deferasirox API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Deferasirox API Market Report

Report Metric Details
Report Name Deferasirox API Market
Segment by Type
  • Purity≥98%
  • Purity<98%
Segment by Application
  • Deferasirox Tablets
  • Others
Production by Region
  • Europe
  • China
  • China Taiwan
  • India
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Piramal Enterprises Limited, Alkaloids Corporation, Zhejiang Hengkang Pharmaceutical, Om Pharmaceutical Industries, Teva API, Symed Labs Limited, Neuland Laboratories, Parabolic Drugs Limited, YUNG ZIP CHEMICAL INDUSTRIAL, Erregierre SpA, Glenmark Pharmaceuticals, Cipla, Sun Pharmaceutical Industries Ltd., Jubilant Pharma, CTX Lifesciences, Waterstone Pharmaceuticals Inc., Bal Pharma Ltd., Curequest Lifescience
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Deferasirox API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Deferasirox API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Deferasirox API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Deferasirox API Market report?

Ans: The main players in the Deferasirox API Market are Piramal Enterprises Limited, Alkaloids Corporation, Zhejiang Hengkang Pharmaceutical, Om Pharmaceutical Industries, Teva API, Symed Labs Limited, Neuland Laboratories, Parabolic Drugs Limited, YUNG ZIP CHEMICAL INDUSTRIAL, Erregierre SpA, Glenmark Pharmaceuticals, Cipla, Sun Pharmaceutical Industries Ltd., Jubilant Pharma, CTX Lifesciences, Waterstone Pharmaceuticals Inc., Bal Pharma Ltd., Curequest Lifescience

What are the Application segmentation covered in the Deferasirox API Market report?

Ans: The Applications covered in the Deferasirox API Market report are Deferasirox Tablets, Others

What are the Type segmentation covered in the Deferasirox API Market report?

Ans: The Types covered in the Deferasirox API Market report are Purity≥98%, Purity<98%

1 Deferasirox API Market Overview
1.1 Product Definition
1.2 Deferasirox API Segment by Type
1.2.1 Global Deferasirox API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Purity≥98%
1.2.3 Purity<98%
1.3 Deferasirox API Segment by Application
1.3.1 Global Deferasirox API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Deferasirox Tablets
1.3.3 Others
1.4 Global Market Growth Prospects
1.4.1 Global Deferasirox API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Deferasirox API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Deferasirox API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Deferasirox API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Deferasirox API Production Market Share by Manufacturers (2019-2024)
2.2 Global Deferasirox API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Deferasirox API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Deferasirox API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Deferasirox API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Deferasirox API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Deferasirox API, Product Offered and Application
2.8 Global Key Manufacturers of Deferasirox API, Date of Enter into This Industry
2.9 Deferasirox API Market Competitive Situation and Trends
2.9.1 Deferasirox API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Deferasirox API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Deferasirox API Production by Region
3.1 Global Deferasirox API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Deferasirox API Production Value by Region (2019-2030)
3.2.1 Global Deferasirox API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Deferasirox API by Region (2025-2030)
3.3 Global Deferasirox API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Deferasirox API Production by Region (2019-2030)
3.4.1 Global Deferasirox API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Deferasirox API by Region (2025-2030)
3.5 Global Deferasirox API Market Price Analysis by Region (2019-2024)
3.6 Global Deferasirox API Production and Value, Year-over-Year Growth
3.6.1 Europe Deferasirox API Production Value Estimates and Forecasts (2019-2030)
3.6.2 China Deferasirox API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Taiwan Deferasirox API Production Value Estimates and Forecasts (2019-2030)
3.6.4 India Deferasirox API Production Value Estimates and Forecasts (2019-2030)
4 Deferasirox API Consumption by Region
4.1 Global Deferasirox API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Deferasirox API Consumption by Region (2019-2030)
4.2.1 Global Deferasirox API Consumption by Region (2019-2024)
4.2.2 Global Deferasirox API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Deferasirox API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Deferasirox API Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Deferasirox API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Deferasirox API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Deferasirox API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Deferasirox API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Deferasirox API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Deferasirox API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Deferasirox API Production by Type (2019-2030)
5.1.1 Global Deferasirox API Production by Type (2019-2024)
5.1.2 Global Deferasirox API Production by Type (2025-2030)
5.1.3 Global Deferasirox API Production Market Share by Type (2019-2030)
5.2 Global Deferasirox API Production Value by Type (2019-2030)
5.2.1 Global Deferasirox API Production Value by Type (2019-2024)
5.2.2 Global Deferasirox API Production Value by Type (2025-2030)
5.2.3 Global Deferasirox API Production Value Market Share by Type (2019-2030)
5.3 Global Deferasirox API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Deferasirox API Production by Application (2019-2030)
6.1.1 Global Deferasirox API Production by Application (2019-2024)
6.1.2 Global Deferasirox API Production by Application (2025-2030)
6.1.3 Global Deferasirox API Production Market Share by Application (2019-2030)
6.2 Global Deferasirox API Production Value by Application (2019-2030)
6.2.1 Global Deferasirox API Production Value by Application (2019-2024)
6.2.2 Global Deferasirox API Production Value by Application (2025-2030)
6.2.3 Global Deferasirox API Production Value Market Share by Application (2019-2030)
6.3 Global Deferasirox API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Piramal Enterprises Limited
7.1.1 Piramal Enterprises Limited Deferasirox API Corporation Information
7.1.2 Piramal Enterprises Limited Deferasirox API Product Portfolio
7.1.3 Piramal Enterprises Limited Deferasirox API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Piramal Enterprises Limited Main Business and Markets Served
7.1.5 Piramal Enterprises Limited Recent Developments/Updates
7.2 Alkaloids Corporation
7.2.1 Alkaloids Corporation Deferasirox API Corporation Information
7.2.2 Alkaloids Corporation Deferasirox API Product Portfolio
7.2.3 Alkaloids Corporation Deferasirox API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Alkaloids Corporation Main Business and Markets Served
7.2.5 Alkaloids Corporation Recent Developments/Updates
7.3 Zhejiang Hengkang Pharmaceutical
7.3.1 Zhejiang Hengkang Pharmaceutical Deferasirox API Corporation Information
7.3.2 Zhejiang Hengkang Pharmaceutical Deferasirox API Product Portfolio
7.3.3 Zhejiang Hengkang Pharmaceutical Deferasirox API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Zhejiang Hengkang Pharmaceutical Main Business and Markets Served
7.3.5 Zhejiang Hengkang Pharmaceutical Recent Developments/Updates
7.4 Om Pharmaceutical Industries
7.4.1 Om Pharmaceutical Industries Deferasirox API Corporation Information
7.4.2 Om Pharmaceutical Industries Deferasirox API Product Portfolio
7.4.3 Om Pharmaceutical Industries Deferasirox API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Om Pharmaceutical Industries Main Business and Markets Served
7.4.5 Om Pharmaceutical Industries Recent Developments/Updates
7.5 Teva API
7.5.1 Teva API Deferasirox API Corporation Information
7.5.2 Teva API Deferasirox API Product Portfolio
7.5.3 Teva API Deferasirox API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Teva API Main Business and Markets Served
7.5.5 Teva API Recent Developments/Updates
7.6 Symed Labs Limited
7.6.1 Symed Labs Limited Deferasirox API Corporation Information
7.6.2 Symed Labs Limited Deferasirox API Product Portfolio
7.6.3 Symed Labs Limited Deferasirox API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Symed Labs Limited Main Business and Markets Served
7.6.5 Symed Labs Limited Recent Developments/Updates
7.7 Neuland Laboratories
7.7.1 Neuland Laboratories Deferasirox API Corporation Information
7.7.2 Neuland Laboratories Deferasirox API Product Portfolio
7.7.3 Neuland Laboratories Deferasirox API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Neuland Laboratories Main Business and Markets Served
7.7.5 Neuland Laboratories Recent Developments/Updates
7.8 Parabolic Drugs Limited
7.8.1 Parabolic Drugs Limited Deferasirox API Corporation Information
7.8.2 Parabolic Drugs Limited Deferasirox API Product Portfolio
7.8.3 Parabolic Drugs Limited Deferasirox API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Parabolic Drugs Limited Main Business and Markets Served
7.7.5 Parabolic Drugs Limited Recent Developments/Updates
7.9 YUNG ZIP CHEMICAL INDUSTRIAL
7.9.1 YUNG ZIP CHEMICAL INDUSTRIAL Deferasirox API Corporation Information
7.9.2 YUNG ZIP CHEMICAL INDUSTRIAL Deferasirox API Product Portfolio
7.9.3 YUNG ZIP CHEMICAL INDUSTRIAL Deferasirox API Production, Value, Price and Gross Margin (2019-2024)
7.9.4 YUNG ZIP CHEMICAL INDUSTRIAL Main Business and Markets Served
7.9.5 YUNG ZIP CHEMICAL INDUSTRIAL Recent Developments/Updates
7.10 Erregierre SpA
7.10.1 Erregierre SpA Deferasirox API Corporation Information
7.10.2 Erregierre SpA Deferasirox API Product Portfolio
7.10.3 Erregierre SpA Deferasirox API Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Erregierre SpA Main Business and Markets Served
7.10.5 Erregierre SpA Recent Developments/Updates
7.11 Glenmark Pharmaceuticals
7.11.1 Glenmark Pharmaceuticals Deferasirox API Corporation Information
7.11.2 Glenmark Pharmaceuticals Deferasirox API Product Portfolio
7.11.3 Glenmark Pharmaceuticals Deferasirox API Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Glenmark Pharmaceuticals Main Business and Markets Served
7.11.5 Glenmark Pharmaceuticals Recent Developments/Updates
7.12 Cipla
7.12.1 Cipla Deferasirox API Corporation Information
7.12.2 Cipla Deferasirox API Product Portfolio
7.12.3 Cipla Deferasirox API Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Cipla Main Business and Markets Served
7.12.5 Cipla Recent Developments/Updates
7.13 Sun Pharmaceutical Industries Ltd.
7.13.1 Sun Pharmaceutical Industries Ltd. Deferasirox API Corporation Information
7.13.2 Sun Pharmaceutical Industries Ltd. Deferasirox API Product Portfolio
7.13.3 Sun Pharmaceutical Industries Ltd. Deferasirox API Production, Value, Price and Gross Margin (2019-2024)
7.13.4 Sun Pharmaceutical Industries Ltd. Main Business and Markets Served
7.13.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
7.14 Jubilant Pharma
7.14.1 Jubilant Pharma Deferasirox API Corporation Information
7.14.2 Jubilant Pharma Deferasirox API Product Portfolio
7.14.3 Jubilant Pharma Deferasirox API Production, Value, Price and Gross Margin (2019-2024)
7.14.4 Jubilant Pharma Main Business and Markets Served
7.14.5 Jubilant Pharma Recent Developments/Updates
7.15 CTX Lifesciences
7.15.1 CTX Lifesciences Deferasirox API Corporation Information
7.15.2 CTX Lifesciences Deferasirox API Product Portfolio
7.15.3 CTX Lifesciences Deferasirox API Production, Value, Price and Gross Margin (2019-2024)
7.15.4 CTX Lifesciences Main Business and Markets Served
7.15.5 CTX Lifesciences Recent Developments/Updates
7.16 Waterstone Pharmaceuticals Inc.
7.16.1 Waterstone Pharmaceuticals Inc. Deferasirox API Corporation Information
7.16.2 Waterstone Pharmaceuticals Inc. Deferasirox API Product Portfolio
7.16.3 Waterstone Pharmaceuticals Inc. Deferasirox API Production, Value, Price and Gross Margin (2019-2024)
7.16.4 Waterstone Pharmaceuticals Inc. Main Business and Markets Served
7.16.5 Waterstone Pharmaceuticals Inc. Recent Developments/Updates
7.17 Bal Pharma Ltd.
7.17.1 Bal Pharma Ltd. Deferasirox API Corporation Information
7.17.2 Bal Pharma Ltd. Deferasirox API Product Portfolio
7.17.3 Bal Pharma Ltd. Deferasirox API Production, Value, Price and Gross Margin (2019-2024)
7.17.4 Bal Pharma Ltd. Main Business and Markets Served
7.17.5 Bal Pharma Ltd. Recent Developments/Updates
7.18 Curequest Lifescience
7.18.1 Curequest Lifescience Deferasirox API Corporation Information
7.18.2 Curequest Lifescience Deferasirox API Product Portfolio
7.18.3 Curequest Lifescience Deferasirox API Production, Value, Price and Gross Margin (2019-2024)
7.18.4 Curequest Lifescience Main Business and Markets Served
7.18.5 Curequest Lifescience Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Deferasirox API Industry Chain Analysis
8.2 Deferasirox API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Deferasirox API Production Mode & Process
8.4 Deferasirox API Sales and Marketing
8.4.1 Deferasirox API Sales Channels
8.4.2 Deferasirox API Distributors
8.5 Deferasirox API Customers
9 Deferasirox API Market Dynamics
9.1 Deferasirox API Industry Trends
9.2 Deferasirox API Market Drivers
9.3 Deferasirox API Market Challenges
9.4 Deferasirox API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
FEATURED COMPANIES
Piramal Enterprises Limited
Alkaloids Corporation
Zhejiang Hengkang Pharmaceutical
Om Pharmaceutical Industries
Teva API
Symed Labs Limited
Neuland Laboratories
Parabolic Drugs Limited
YUNG ZIP CHEMICAL INDUSTRIAL
Erregierre SpA
Glenmark Pharmaceuticals
Cipla Ltd
Sun Pharmaceutical Industries Ltd.
Jubilant Pharma
CTX Lifesciences
Waterstone Pharmaceuticals Inc.
Curequest Lifescience
Bal Pharma Ltd.
List of Tables
    Table 1. Global Deferasirox API Market Value by Type, (US$ Million) & (2023 VS 2030)
    Table 2. Global Deferasirox API Market Value by Application, (US$ Million) & (2023 VS 2030)
    Table 3. Global Deferasirox API Production Capacity (Kiloton) by Manufacturers in 2023
    Table 4. Global Deferasirox API Production by Manufacturers (2019-2024) & (Kiloton)
    Table 5. Global Deferasirox API Production Market Share by Manufacturers (2019-2024)
    Table 6. Global Deferasirox API Production Value by Manufacturers (2019-2024) & (US$ Million)
    Table 7. Global Deferasirox API Production Value Share by Manufacturers (2019-2024)
    Table 8. Global Deferasirox API Industry Ranking 2022 VS 2023 VS 2024
    Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Deferasirox API as of 2023)
    Table 10. Global Market Deferasirox API Average Price by Manufacturers (US$/Ton) & (2019-2024)
    Table 11. Manufacturers Deferasirox API Production Sites and Area Served
    Table 12. Manufacturers Deferasirox API Product Types
    Table 13. Global Deferasirox API Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Mergers & Acquisitions, Expansion
    Table 15. Global Deferasirox API Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 16. Global Deferasirox API Production Value (US$ Million) by Region (2019-2024)
    Table 17. Global Deferasirox API Production Value Market Share by Region (2019-2024)
    Table 18. Global Deferasirox API Production Value (US$ Million) Forecast by Region (2025-2030)
    Table 19. Global Deferasirox API Production Value Market Share Forecast by Region (2025-2030)
    Table 20. Global Deferasirox API Production Comparison by Region: 2019 VS 2023 VS 2030 (Kiloton)
    Table 21. Global Deferasirox API Production (Kiloton) by Region (2019-2024)
    Table 22. Global Deferasirox API Production Market Share by Region (2019-2024)
    Table 23. Global Deferasirox API Production (Kiloton) Forecast by Region (2025-2030)
    Table 24. Global Deferasirox API Production Market Share Forecast by Region (2025-2030)
    Table 25. Global Deferasirox API Market Average Price (US$/Ton) by Region (2019-2024)
    Table 26. Global Deferasirox API Market Average Price (US$/Ton) by Region (2025-2030)
    Table 27. Global Deferasirox API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Kiloton)
    Table 28. Global Deferasirox API Consumption by Region (2019-2024) & (Kiloton)
    Table 29. Global Deferasirox API Consumption Market Share by Region (2019-2024)
    Table 30. Global Deferasirox API Forecasted Consumption by Region (2025-2030) & (Kiloton)
    Table 31. Global Deferasirox API Forecasted Consumption Market Share by Region (2019-2024)
    Table 32. North America Deferasirox API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Kiloton)
    Table 33. North America Deferasirox API Consumption by Country (2019-2024) & (Kiloton)
    Table 34. North America Deferasirox API Consumption by Country (2025-2030) & (Kiloton)
    Table 35. Europe Deferasirox API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Kiloton)
    Table 36. Europe Deferasirox API Consumption by Country (2019-2024) & (Kiloton)
    Table 37. Europe Deferasirox API Consumption by Country (2025-2030) & (Kiloton)
    Table 38. Asia Pacific Deferasirox API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Kiloton)
    Table 39. Asia Pacific Deferasirox API Consumption by Region (2019-2024) & (Kiloton)
    Table 40. Asia Pacific Deferasirox API Consumption by Region (2025-2030) & (Kiloton)
    Table 41. Latin America, Middle East & Africa Deferasirox API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Kiloton)
    Table 42. Latin America, Middle East & Africa Deferasirox API Consumption by Country (2019-2024) & (Kiloton)
    Table 43. Latin America, Middle East & Africa Deferasirox API Consumption by Country (2025-2030) & (Kiloton)
    Table 44. Global Deferasirox API Production (Kiloton) by Type (2019-2024)
    Table 45. Global Deferasirox API Production (Kiloton) by Type (2025-2030)
    Table 46. Global Deferasirox API Production Market Share by Type (2019-2024)
    Table 47. Global Deferasirox API Production Market Share by Type (2025-2030)
    Table 48. Global Deferasirox API Production Value (US$ Million) by Type (2019-2024)
    Table 49. Global Deferasirox API Production Value (US$ Million) by Type (2025-2030)
    Table 50. Global Deferasirox API Production Value Share by Type (2019-2024)
    Table 51. Global Deferasirox API Production Value Share by Type (2025-2030)
    Table 52. Global Deferasirox API Price (US$/Ton) by Type (2019-2024)
    Table 53. Global Deferasirox API Price (US$/Ton) by Type (2025-2030)
    Table 54. Global Deferasirox API Production (Kiloton) by Application (2019-2024)
    Table 55. Global Deferasirox API Production (Kiloton) by Application (2025-2030)
    Table 56. Global Deferasirox API Production Market Share by Application (2019-2024)
    Table 57. Global Deferasirox API Production Market Share by Application (2025-2030)
    Table 58. Global Deferasirox API Production Value (US$ Million) by Application (2019-2024)
    Table 59. Global Deferasirox API Production Value (US$ Million) by Application (2025-2030)
    Table 60. Global Deferasirox API Production Value Share by Application (2019-2024)
    Table 61. Global Deferasirox API Production Value Share by Application (2025-2030)
    Table 62. Global Deferasirox API Price (US$/Ton) by Application (2019-2024)
    Table 63. Global Deferasirox API Price (US$/Ton) by Application (2025-2030)
    Table 64. Piramal Enterprises Limited Deferasirox API Corporation Information
    Table 65. Piramal Enterprises Limited Specification and Application
    Table 66. Piramal Enterprises Limited Deferasirox API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 67. Piramal Enterprises Limited Main Business and Markets Served
    Table 68. Piramal Enterprises Limited Recent Developments/Updates
    Table 69. Alkaloids Corporation Deferasirox API Corporation Information
    Table 70. Alkaloids Corporation Specification and Application
    Table 71. Alkaloids Corporation Deferasirox API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 72. Alkaloids Corporation Main Business and Markets Served
    Table 73. Alkaloids Corporation Recent Developments/Updates
    Table 74. Zhejiang Hengkang Pharmaceutical Deferasirox API Corporation Information
    Table 75. Zhejiang Hengkang Pharmaceutical Specification and Application
    Table 76. Zhejiang Hengkang Pharmaceutical Deferasirox API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 77. Zhejiang Hengkang Pharmaceutical Main Business and Markets Served
    Table 78. Zhejiang Hengkang Pharmaceutical Recent Developments/Updates
    Table 79. Om Pharmaceutical Industries Deferasirox API Corporation Information
    Table 80. Om Pharmaceutical Industries Specification and Application
    Table 81. Om Pharmaceutical Industries Deferasirox API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 82. Om Pharmaceutical Industries Main Business and Markets Served
    Table 83. Om Pharmaceutical Industries Recent Developments/Updates
    Table 84. Teva API Deferasirox API Corporation Information
    Table 85. Teva API Specification and Application
    Table 86. Teva API Deferasirox API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 87. Teva API Main Business and Markets Served
    Table 88. Teva API Recent Developments/Updates
    Table 89. Symed Labs Limited Deferasirox API Corporation Information
    Table 90. Symed Labs Limited Specification and Application
    Table 91. Symed Labs Limited Deferasirox API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 92. Symed Labs Limited Main Business and Markets Served
    Table 93. Symed Labs Limited Recent Developments/Updates
    Table 94. Neuland Laboratories Deferasirox API Corporation Information
    Table 95. Neuland Laboratories Specification and Application
    Table 96. Neuland Laboratories Deferasirox API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 97. Neuland Laboratories Main Business and Markets Served
    Table 98. Neuland Laboratories Recent Developments/Updates
    Table 99. Parabolic Drugs Limited Deferasirox API Corporation Information
    Table 100. Parabolic Drugs Limited Specification and Application
    Table 101. Parabolic Drugs Limited Deferasirox API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 102. Parabolic Drugs Limited Main Business and Markets Served
    Table 103. Parabolic Drugs Limited Recent Developments/Updates
    Table 104. YUNG ZIP CHEMICAL INDUSTRIAL Deferasirox API Corporation Information
    Table 105. YUNG ZIP CHEMICAL INDUSTRIAL Specification and Application
    Table 106. YUNG ZIP CHEMICAL INDUSTRIAL Deferasirox API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 107. YUNG ZIP CHEMICAL INDUSTRIAL Main Business and Markets Served
    Table 108. YUNG ZIP CHEMICAL INDUSTRIAL Recent Developments/Updates
    Table 109. Erregierre SpA Deferasirox API Corporation Information
    Table 110. Erregierre SpA Specification and Application
    Table 111. Erregierre SpA Deferasirox API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 112. Erregierre SpA Main Business and Markets Served
    Table 113. Erregierre SpA Recent Developments/Updates
    Table 114. Glenmark Pharmaceuticals Deferasirox API Corporation Information
    Table 115. Glenmark Pharmaceuticals Specification and Application
    Table 116. Glenmark Pharmaceuticals Deferasirox API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 117. Glenmark Pharmaceuticals Main Business and Markets Served
    Table 118. Glenmark Pharmaceuticals Recent Developments/Updates
    Table 119. Cipla Deferasirox API Corporation Information
    Table 120. Cipla Specification and Application
    Table 121. Cipla Deferasirox API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 122. Cipla Main Business and Markets Served
    Table 123. Cipla Recent Developments/Updates
    Table 124. Sun Pharmaceutical Industries Ltd. Deferasirox API Corporation Information
    Table 125. Sun Pharmaceutical Industries Ltd. Specification and Application
    Table 126. Sun Pharmaceutical Industries Ltd. Deferasirox API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 127. Sun Pharmaceutical Industries Ltd. Main Business and Markets Served
    Table 128. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
    Table 129. Jubilant Pharma Deferasirox API Corporation Information
    Table 130. Jubilant Pharma Specification and Application
    Table 131. Jubilant Pharma Deferasirox API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 132. Jubilant Pharma Main Business and Markets Served
    Table 133. Jubilant Pharma Recent Developments/Updates
    Table 134. Jubilant Pharma Deferasirox API Corporation Information
    Table 135. CTX Lifesciences Specification and Application
    Table 136. CTX Lifesciences Deferasirox API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 137. CTX Lifesciences Main Business and Markets Served
    Table 138. CTX Lifesciences Recent Developments/Updates
    Table 139. Waterstone Pharmaceuticals Inc. Deferasirox API Corporation Information
    Table 140. Waterstone Pharmaceuticals Inc. Deferasirox API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 141. Waterstone Pharmaceuticals Inc. Main Business and Markets Served
    Table 142. Waterstone Pharmaceuticals Inc. Recent Developments/Updates
    Table 143. Bal Pharma Ltd. Deferasirox API Corporation Information
    Table 144. Bal Pharma Ltd. Specification and Application
    Table 145. Bal Pharma Ltd. Deferasirox API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 146. Bal Pharma Ltd. Main Business and Markets Served
    Table 147. Bal Pharma Ltd. Recent Developments/Updates
    Table 148. Curequest Lifescience Deferasirox API Corporation Information
    Table 149. Curequest Lifescience Specification and Application
    Table 150. Curequest Lifescience Deferasirox API Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 151. Curequest Lifescience Main Business and Markets Served
    Table 152. Curequest Lifescience Recent Developments/Updates
    Table 153. Key Raw Materials Lists
    Table 154. Raw Materials Key Suppliers Lists
    Table 155. Deferasirox API Distributors List
    Table 156. Deferasirox API Customers List
    Table 157. Deferasirox API Market Trends
    Table 158. Deferasirox API Market Drivers
    Table 159. Deferasirox API Market Challenges
    Table 160. Deferasirox API Market Restraints
    Table 161. Research Programs/Design for This Report
    Table 162. Key Data Information from Secondary Sources
    Table 163. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Deferasirox API
    Figure 2. Global Deferasirox API Market Value by Type, (US$ Million) & (2023 VS 2030)
    Figure 3. Global Deferasirox API Market Share by Type: 2023 VS 2030
    Figure 4. Purity≥98% Product Picture
    Figure 5. Purity<98% Product Picture
    Figure 6. Global Deferasirox API Market Value by Application, (US$ Million) & (2023 VS 2030)
    Figure 7. Global Deferasirox API Market Share by Application: 2023 VS 2030
    Figure 8. Deferasirox Tablets
    Figure 9. Others
    Figure 10. Global Deferasirox API Production Value (US$ Million), 2019 VS 2023 VS 2030
    Figure 11. Global Deferasirox API Production Value (US$ Million) & (2019-2030)
    Figure 12. Global Deferasirox API Production Capacity (Kiloton) & (2019-2030)
    Figure 13. Global Deferasirox API Production (Kiloton) & (2019-2030)
    Figure 14. Global Deferasirox API Average Price (US$/Ton) & (2019-2030)
    Figure 15. Deferasirox API Report Years Considered
    Figure 16. Deferasirox API Production Share by Manufacturers in 2023
    Figure 17. Deferasirox API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 18. The Global 5 and 10 Largest Players: Market Share by Deferasirox API Revenue in 2023
    Figure 19. Global Deferasirox API Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Figure 20. Global Deferasirox API Production Value Market Share by Region: 2019 VS 2023 VS 2030
    Figure 21. Global Deferasirox API Production Comparison by Region: 2019 VS 2023 VS 2030 (Kiloton)
    Figure 22. Global Deferasirox API Production Market Share by Region: 2019 VS 2023 VS 2030
    Figure 23. Europe Deferasirox API Production Value (US$ Million) Growth Rate (2019-2030)
    Figure 24. China Deferasirox API Production Value (US$ Million) Growth Rate (2019-2030)
    Figure 25. China Taiwan Deferasirox API Production Value (US$ Million) Growth Rate (2019-2030)
    Figure 26. India Deferasirox API Production Value (US$ Million) Growth Rate (2019-2030)
    Figure 27. Global Deferasirox API Consumption by Region: 2019 VS 2023 VS 2030 (Kiloton)
    Figure 28. Global Deferasirox API Consumption Market Share by Region: 2019 VS 2023 VS 2030
    Figure 29. North America Deferasirox API Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 30. North America Deferasirox API Consumption Market Share by Country (2019-2030)
    Figure 31. Canada Deferasirox API Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 32. U.S. Deferasirox API Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 33. Europe Deferasirox API Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 34. Europe Deferasirox API Consumption Market Share by Country (2019-2030)
    Figure 35. Germany Deferasirox API Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 36. France Deferasirox API Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 37. U.K. Deferasirox API Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 38. Italy Deferasirox API Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 39. Russia Deferasirox API Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 40. Asia Pacific Deferasirox API Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 41. Asia Pacific Deferasirox API Consumption Market Share by Regions (2019-2030)
    Figure 42. China Deferasirox API Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 43. Japan Deferasirox API Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 44. South Korea Deferasirox API Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 45. China Taiwan Deferasirox API Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 46. Southeast Asia Deferasirox API Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 47. India Deferasirox API Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 48. Latin America, Middle East & Africa Deferasirox API Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 49. Latin America, Middle East & Africa Deferasirox API Consumption Market Share by Country (2019-2030)
    Figure 50. Mexico Deferasirox API Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 51. Brazil Deferasirox API Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 52. Turkey Deferasirox API Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 53. GCC Countries Deferasirox API Consumption and Growth Rate (2019-2024) & (Kiloton)
    Figure 54. Global Production Market Share of Deferasirox API by Type (2019-2030)
    Figure 55. Global Production Value Market Share of Deferasirox API by Type (2019-2030)
    Figure 56. Global Deferasirox API Price (US$/Ton) by Type (2019-2030)
    Figure 57. Global Production Market Share of Deferasirox API by Application (2019-2030)
    Figure 58. Global Production Value Market Share of Deferasirox API by Application (2019-2030)
    Figure 59. Global Deferasirox API Price (US$/Ton) by Application (2019-2030)
    Figure 60. Deferasirox API Value Chain
    Figure 61. Deferasirox API Production Process
    Figure 62. Channels of Distribution (Direct Vs Distribution)
    Figure 63. Distributors Profiles
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Substrate Cutting Device Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-23Z18292
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Targeted Radionuclide Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-14Z15017
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global Microfluidic Single-Cell Analysis and Screening System Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-7M18883
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Medicinal Liquid Filling Equipment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-37J14968
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions